A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone
Harthik Parankusham,
Casey Vanderlip,
Colin Birkenbihl,
Eashwar Krishna,
Chizobam Ugboaja,
Andrew E. Budson,
Brandon Frank,
for the Alzheimer's Disease Neuroimaging Initiative Annals of Clinical and Translational Neurology
· Wiley
· 2026-10-20
· DOI: 10.1002/acn3.70560
The publisher did not provide an abstract — full text is available via the link below.
Harthik Parankusham, Casey Vanderlip, Colin Birkenbihl, Eashwar Krishna, Chizobam Ugboaja, Andrew E. Budson et al. A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone. // Annals of Clinical and Translational Neurology. – 2026. – DOI: 10.1002/acn3.70560. – URL: https://onlinelibrary.wiley.com/doi/10.1002/acn3.70560?af=R
Harthik Parankusham, Casey Vanderlip, Colin Birkenbihl, Eashwar Krishna, Chizobam Ugboaja, Andrew E. Budson, Brandon Frank, & for the Alzheimer's Disease Neuroimaging Initiative (2026). A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70560
Harthik Parankusham, et al. “A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone.” Annals of Clinical and Translational Neurology, 2026. doi:10.1002/acn3.70560.
@article{Parankusham2026,
title = {A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone},
author = {Parankusham, Harthik and Vanderlip, Casey and Birkenbihl, Colin and Krishna, Eashwar and Ugboaja, Chizobam and Budson, Andrew E. and Frank, Brandon and Initiative, for the Alzheimer's Disease Neuroimaging},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70560},
url = {https://onlinelibrary.wiley.com/doi/10.1002/acn3.70560?af=R}
}